检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:Sheetal Porecha Acharya K.Pundarikakshudu Aashish Panchal Anita Lalwani
机构地区:[1]l.10.institute of pharmacy and research centre,ahmedabad,gujarat 382210,india [2]kadi sarva vishwavidyalaya,sector 15/23,gandhinagar,gujarat,india
出 处:《Asian Journal of Pharmaceutical Sciences》2013年第1期64-70,共7页亚洲药物制剂科学(英文)
基 金:This study was supported by a grant from Gujarat Council of Scientific Technology(GUJCOST),Ahmedabad.
摘 要:The objective of this study was to develop novel transanasl microemulsion containing carbamazepine for treatment of epilepsy.Oleic acid was selected as oil while Tween 80 and propylene glycol were selected as surfactant and cosurfactant respectively based on solubility results.Optimized ratio of Tween 80:propylene glycol was selected after developing pseudoternary phase diagrams for different ratio and microemulsions were prepared.The prepared microemulsions were evaluated for globule size,viscosity,pH,conductivity and%transmittance.Exvivo diffusion study for optimized microemulsion was performed through sheep nasal mucosa wherein diffusion flux and permeability coefficients were determined.Further pharmacodynamic performance was evaluated in rats by electrically induced seizures.It was found that optimized microemulsion was stable and transparent with average globule size of 190 nm and diffusion flux of 75.77 mg cm2 min1 and showed no toxicity during histopathological evaluation on sheep nasal mucosa.Pharmacodynamic evaluation also indicated lesser intensity of seizures in rats treated with optimized formulation in comparison to rats treated with oral carbamazepine microemulsion and nasal carbamazepine solution which suggested carbamazepine transnasal delivery system as an effective alternate therapy for treatment of epilepsy.
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.3